MedPath

Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women

Phase 4
Completed
Conditions
Melasma
Interventions
Drug: 20-30% Salicylic Acid peels to the right side of the face
Drug: 20-30% Salicylic Acid peels to the left side of the face
Registration Number
NCT00616239
Lead Sponsor
University of Texas Southwestern Medical Center
Brief Summary

This study will enroll 20 adult Hispanic women. Participants will apply 4% hydroquinone cream twice daily to affected areas on the face for 14 weeks and half the face will be peeled with 20-30% salicylic acid every two weeks for a total of 4 peels. The first two peels will be 20% salicylic acid and the second two peels will be with 30% salicylic acid. The purpose of the study will be to evaluate the safety and efficacy of salicylic acid combined with 4% hydroquinone versus 4% hydroquinone alone.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
20
Inclusion Criteria
  • Hispanic women ages 18-65 years of age with moderate to severe melasma
  • English and Spanish-speaking women
Exclusion Criteria
  • Pregnant or breast-feeding women
  • Subjects who have used 4% hydroquinone within 3 months of study start
  • Subjects who have used chemical peels, microdermabrasion or facial laser treatments within 9 months of study start

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
A20-30% Salicylic Acid peels to the right side of the faceSubjects randomized to have the right side of the face peeled with salicylic acid every 2 weeks for a total of 4 peels (first 2 at 20% and last 2 at 30%). Subjects will apply 4% hydroquinone cream to affected areas on entire face for 14 weeks.
B20-30% Salicylic Acid peels to the left side of the faceSubjects randomized to have the left side of the face peeled with salicylic acid every 2 weeks for a total of 4 peels (first 2 at 20% and last 2 at 30%). Subjects will apply 4% hydroquinone cream to affected areas on entire face for 14 weeks.
Primary Outcome Measures
NameTimeMethod
Number of Participants Showing Improvement of Melasma Based on Mexameter Readings14 weeks

Improvement of melasma on the peel side using mexameter reading

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials

🇺🇸

Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath